F10 and interstitial nephritis: A significant inverse association with tubulointerstitial nephritis adverse events was found for FXa inhibitors (ROR, 0.65; 95% CI, 0.49–0.85), but not warfarin (ROR, 0.94; 95% CI, 0.76–1.16).